PTK2 and breast cancer: Decreased expression and proteolytic activity of MMP-9 and MMP-2 were observed in breast tumors after NC-based treatment, suggesting that treatment with NC at a low concentration inhibits breast cancer cell metastasis by suppressing the Src/FAK signaling pathway [87].